New Challenges in Method Development, Emerging Approaches for Regulated Bioanalysis from Discovery Bioanalysis And Latest Regulatory Inputs from Major Health Authorities around the Globe

A Bioanalytical Week at WRIB

Over 600 professionals representing pharmas, biopharmas, biotechs, CROs and multiple regulatory agencies working on both small and large molecules bioanalysis participated in the 9th WRIB (Workshop on Recent Issues in Bioanalysis) - a bioanalytical week on April 13-17, 2015 in Miami, Florida, USA.
The 2015 White Paper in Bioanalysis from this meeting will be divided into 3 parts based on the topics and will be published on Journal Bioanaysisthis summer.

Built on the previous successes, the 9th WRIB continued to be a discussion forum where regulators and industry convene for working together in the field of bioanalysis to improve global health.

Based on the survey results from our previous attendees, the 9th WRIB featured again the novel and unique 3-day Sequential Programduring the Main Workshop Days (Day 1, Day 2, and Day 3) with no parallel/overlapping sessions - specifically designed to maximize the learning process at any level in your field of expertise: Small Molecules, Large Molecules, LCMS, LBA, Biomarkers, and Immunogenicity.

In addition to the 3-day main workshop, 6 training courses (LCMS, LBA and Hybrid LBA/LCMS) were offered during the week to allow the flexibility to choose different combination of courses & workshop days based on each attendee's track of interest.

Participating Regulators at 9th WRIB again included all major Regulatory Agencies in North America, Europe, Latin America, and Asia: